Article and Video CATEGORIES
2021 LIVE ONLINE
Targeted Therapies Patient Forum
July 17, 2021 10:00 AM Eastern
Register Now!
Join us once again for this highly anticipated annual livestreamed event, featuring top oncologists in their field presenting the most current and emerging information in targeted therapies and answering patient questions in real time.
Registration is now open!
The latest information about our Targeted Therapies Forum will always be available at www.cancergrace.org.
If you have any questions regarding your registration, please email us at info@cancerGRACE.org.
Join GRACE Live ONLINE July 17, 10:00 AM Eastern
Register Below for the GRACE 2021 Targeted Therapies Patient Forum!
This virtual event will be held LIVE ONLINE
For Details - Please View the full Agenda and the Faculty Information for more information!
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Hi Bluebird, Welcome to GRACE. I'm sorry you're going through this scare and hope it's just inflammation or from an infection you didn't know you had.
A CT would be...
Radiation + Brain Operation has just been discarded due to high risk. They will double Tagrisso dosis and then wait to see if it works, then try traditional Chemo. I would...
Recent Comments
That's…
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...